123 related articles for article (PubMed ID: 8139088)
1. Comparison of the effects of exercise and isoproterenol on the antegrade refractory period of the accessory pathway in patients with Wolff-Parkinson-White syndrome.
Yamabe H; Okumura K; Yasue H
Jpn Circ J; 1994 Jan; 58(1):22-8. PubMed ID: 8139088
[TBL] [Abstract][Full Text] [Related]
2. Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome.
Chimienti M; Li Bergolis M; Moizi M; Klersy C; Negroni MS; Salerno JA
Pacing Clin Electrophysiol; 1992 Aug; 15(8):1158-66. PubMed ID: 1381084
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic effects of isoproterenol in children with Wolff-Parkinson-White syndrome].
Fujiseki Y; Fujino H; Hattori M; Kamiya Y; Nishijima S; Umemura N; Shimada M; Sugiyama T; Matsukawa S; Nishikawa R
Kokyu To Junkan; 1989 Feb; 37(2):189-94. PubMed ID: 2727406
[TBL] [Abstract][Full Text] [Related]
4. [Effect of heart rate on the refractory period of the accessory atrioventricular pathway in Wolff-Parkinson-White syndrome].
Fromer M; Gloor H; Kappenberger L
Schweiz Med Wochenschr; 1985 Nov; 115(44):1545-51. PubMed ID: 4081683
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern.
Satoh M; Aizawa Y; Funazaki T; Niwano S; Ebe K; Miyajima S; Suzuki K; Aizawa M; Shibata A
Pacing Clin Electrophysiol; 1989 Mar; 12(3):413-20. PubMed ID: 2466266
[TBL] [Abstract][Full Text] [Related]
6. Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome.
Daubert C; Ollitrault J; Descaves C; Mabo P; Ritter P; Gouffault J
Pacing Clin Electrophysiol; 1988 Aug; 11(8):1130-8. PubMed ID: 2459665
[TBL] [Abstract][Full Text] [Related]
7. Effects of isoproterenol on accessory pathway conduction in intermittent or concealed Wolff-Parkinson-White syndrome.
Yamamoto T; Yeh SJ; Lin FC; Wu DL
Am J Cardiol; 1990 Jun; 65(22):1438-42. PubMed ID: 2353648
[TBL] [Abstract][Full Text] [Related]
8. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
9. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Inoue H; Zipes DP
Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
[TBL] [Abstract][Full Text] [Related]
10. Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Can J Anaesth; 1992 Oct; 39(8):816-21. PubMed ID: 1288908
[TBL] [Abstract][Full Text] [Related]
11. Comparison of exercise and ajmaline tests with electrophysiologic study in the Wolff-Parkinson-White syndrome.
Eshchar Y; Belhassen B; Laniado S
Am J Cardiol; 1986 Apr; 57(10):782-6. PubMed ID: 3962865
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern.
Kubuš P; Vít P; Gebauer RA; Materna O; Janoušek J
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):218-23. PubMed ID: 24488978
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of intravenous propafenone at rest, during isoproterenol infusion and during exercise in the Wolff-Parkinson-White syndrome.
Goy JJ; Fromer M; Schlaepfer J; Kappenberger L
Am J Cardiol; 1991 Sep; 68(6):681-4. PubMed ID: 1877490
[No Abstract] [Full Text] [Related]
14. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
Favale S; Minafra F; Massari V; Tritto M; Rizzon P
Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
[TBL] [Abstract][Full Text] [Related]
15. Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
Klein GJ; Yee R; Sharma AD
Circulation; 1984 Sep; 70(3):402-11. PubMed ID: 6744543
[TBL] [Abstract][Full Text] [Related]
16. Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
Brembilla-Perrot B; Admant P; Le Helloco A; Pernot C
Eur Heart J; 1985 Dec; 6(12):1074-8. PubMed ID: 3830711
[TBL] [Abstract][Full Text] [Related]
17. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
18. [An electrophysiologic and electropharmacological study of functional properties of the bundle of Kent in Wolff-Parkinson-White syndrome].
Costantini M; Chimienti M; Zardini M; Klersy C; Guasti L; Salerno JA
Cardiologia; 1989 Apr; 34(4):365-74. PubMed ID: 2758442
[TBL] [Abstract][Full Text] [Related]
19. Propofol has no direct effect on sinoatrial node function or on normal atrioventricular and accessory pathway conduction in Wolff-Parkinson-White syndrome during alfentanil/midazolam anesthesia.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Yee R
Anesthesiology; 1995 Apr; 82(4):888-95. PubMed ID: 7717560
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological effects of ibutilide in patients with accessory pathways.
Glatter KA; Dorostkar PC; Yang Y; Lee RJ; Van Hare GF; Keung E; Modin G; Scheinman MM
Circulation; 2001 Oct; 104(16):1933-9. PubMed ID: 11602497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
